Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

November 1, 2025

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

Azithromycin

A single daily oral dose of Azithromycin tablet 500 mg for five days

DRUG

Methylprednisolone

methylprednisolone 500 mg single intra-venous daily dose for three days

Trial Locations (2)

Assiut university-Faculty of Medicine, Asyut

Faculty of Medicine Assuit University, Asyut

All Listed Sponsors

lead

Assiut University

OTHER